Publication:
G12 mutations rewire allosteric communication at the Ras-RalGDS interface

Placeholder

School / College / Institute

Program

KU Authors

Co-Authors

Jang H
Nussinov R

Editor & Affiliation

Compiler & Affiliation

Translator

Other Contributor

Date

Language

Embargo Status

No

Journal Title

Journal ISSN

Volume Title

Alternative Title

Abstract

The Ras subfamily is the most extensively studied branch of the Ras superfamily, with 20% of all human tumors having activating mutations in one of the RAS genes. Recent studies have shown that the Ras/RalGDS/Ral pathway plays a more significant role in the progression of Ras-driven colon and pancreatic cancers than the Ras/Raf and Ras/PI3K pathways. In this study, we investigated the interaction between Ras and the Ras/Rap binding domain (RBD) of RalGDS using long-timescale molecular dynamics simulations. The binding free energy of dimerization showed that Rap1-RBD has the strongest interaction and M-Ras-RBD the weakest interaction among the simulated systems, consistent with experimental results. We noticed that Ras uses the same acidic interface residues when binding to the complementary basic residues of RalGDS and Raf. By analyzing bonding profiles, we identified several conserved interactions across different systems as well as isoform- and mutant-specific preferences. Our results demonstrate that G12D/V mutations favor Glu37-mediated stabilization, specifically through the Glu37Ras-Ser817RBD hydrogen bond and the Glu37Ras-Tyr815RBD anion-π interaction. By mapping interface allosteric communication pathways, we illustrated the interplay between these stabilizing interactions and allosteric signal transduction across the dimer. We hypothesize that communication between the Ras active site and the RalGDS RBD is rewired upon G12 mutations. Specifically, we identified the GTP-Gly/Asp/Val12Ras-Gln61Ras-Tyr64Ras-Ile36Ras-Ile803RBD pathway that exhibits divergent behavior in wild-type versus mutant systems. The interaction dynamics represented here may serve as a good reference point for studies aiming to develop mutant-specific targeting against tumors harboring Ral overactivity.

Source

Publisher

CellPress

Subject

Molecular biology, Cancer research

Citation

Has Part

Source

Biophysical Journal

Book Series Title

Edition

DOI

10.1016/j.bpj.2026.01.053

item.page.datauri

Link

Rights

Copyrighted

Copyrights Note

Endorsement

Review

Supplemented By

Referenced By

Related Goal

0

Views

0

Downloads

View PlumX Details